Anti-hyperlipidemic and insulin sensitizing activities of fenofibrate reduces aortic lipid deposition in hyperlipidemic Golden Syrian hamster

Molecular and Cellular Biochemistry

Volumn 345, Issue 1-2, 2010, Pages 197-206

  Srivastava, Rai Ajit K ^a   He, Shirley ^a,b  

^a Esperion Therapeutics Inc   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Animal model; Atherosclerosis; Fenofibrate; Hamster; HFHC (high fat high cholesterol); Insulin resistance; IR (insulin receptor); LPL (lipoprotein lipase); PPAR (peroxisome proliferator activated receptor); PTP1B (protein tyrosine phosphatase 1B)

Indexed keywords

FENOFIBRATE; FRUCTOSE; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE 1B; ROSIGLITAZONE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTILIPIDEMIC ACTIVITY; AORTA; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFICACY; HAMSTER; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID STORAGE; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WEIGHT GAIN;

ANIMALS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL; CRICETINAE; DIETARY FATS; FENOFIBRATE; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; INSULIN RESISTANCE; LIPID METABOLISM; MESOCRICETUS; MODELS, ANIMAL; PPAR ALPHA; WEIGHT GAIN;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS; MUS;

EID: 78449298399     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0573-8     Document Type: Article

References (31)

1. J Shepherd MJ Caslake AR Lorimer BD Vallance CJ Packard 1985 Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjects Arteriosclerosis 5 162 168 1:STN:280:DyaL2M7kvVyitw%3D%3D 3977776
2. S Bilz S Wagner M Schmitz A Bedynek U Keller T Demant 2004 Effects of atorvastatin versus fenofibrate on apolipoprotein B-100 and apolipoprotein A-I kinetics in mixed hyperlipidemia J Lipid Res 45 174 185 1:CAS:528: DC%2BD2cXhsVSktr8%3D 10.1194/jlr.M300309-JLR200 14523053
3. RAK Srivastava R Jahagirdar S Azhar S Sharma CL Bisgaier 2006 Peroxisome proliferator-activated receptor-α-selective ligand reduces adiposity, improves insulin sensitivity, and inhibits atherosclerosis in LDL receptor-deficient mice Mol Cell Biochem 285 35 50 1:CAS:528: DC%2BD28XjvFGiurc%3D 10.1007/s11010-005-9053-y 16477380
4. AC Li CJ Binder A Gutierrez KK Brown CR Plotkin JW Pattison AF Valledor RA Davis TM Willson JL Witztum J Palinski CK Glass 2004 Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ J Clin Investig 114 1564 1576 1:CAS:528: DC%2BD2cXhtVKhurzE 15578089
5. H Duez Y Chao M Hernandez G Torpier P Poulain S Mundt Z Mallat E Teissier CA Burton A Tedgui J Fruchart C Fiévet SD Wright B Staels 2002 Reduction of atherosclerosis by the peroxisome proliferator-activated receptor α agonist fenofibrate in mice J Biol Chem 277 48051 48057 1:CAS:528: DC%2BD38Xptlehu7w%3D 10.1074/jbc.M206966200 12377786
6. CC van der Hoogt W de Haan M Westerterp M Hoekstra GM Dallinga-Thie JA Romijn HMG Princen JW Jukema LM Havekes PCN Rensen 2007 Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression J Lipid Res 48 1763 1771 10.1194/jlr.M700108-JLR200 17525476
7. M Guérin E Bruckert PJ Dolphin G Turpin MJ Chapman 1996 Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia Arterioscler Thromb Vasc Biol 11 763 772
8. RAK Srivastava S Jiao J Tang B Pfleger RT Kitchens G Schonfeld 1991 In vivo regulation of low density lipoprotein receptor and apolipoprotein B gene expressions in inbred strains of mice by dietary fatty acids and cholesterol Biochim Biophys Acta 1086 29 43 1:CAS:528:DyaK3MXmtlWju7w%3D 1683257
9. DK Spady JM Dietschy 1988 Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat J Lipid Res 24 303 315
10. SE Dorfman DE Smith DP Osgood AH Lichtenstein 2003 Study on diet-induced changes in lipoprotein metabolism in two strains of Golden-Syrian hamsters J Nutr 133 4183 4188 1:CAS:528:DC%2BD3sXpslGmur0%3D 14652369
11. A Carpentier C Taghibiglou N Leung L Szeto SC Van Iderstine KD Uffelman R Buckingham K Adeli GF Lewis 2002 Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in fructose-fed hamster J Biol Chem 277 28795 28802 1:CAS:528: DC%2BD38XmsVGqur0%3D 10.1074/jbc.M204568200 12048212
12. A Nistor A Bulla DA Filip A Radu 1987 The hyperlipidemic hamster as a model of experimental atherosclerosis Atherosclerosis 68 159 173 1:CAS:528:DyaL1cXjsFOiug%3D%3D 10.1016/0021-9150(87)90106-7 3689479
13. Q Guo PR Wang DP Milot MC Ippolito M Hernandez CA Burton SD Wright Y Chao 2001 Regulation of lipid metabolism and gene expression by fenofibrate in hamsters Biochim Biophys Acta 1533 220 232 1:CAS:528:DC%2BD3MXovVCntL8%3D 11731332
14. PR Wang Q Guo M Ippolito M Wu D Milot J Ventre T Doebber SD Wright Y Chao 2001 High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists Eur J Pharmacol 21 427 285 293 10.1016/S0014-2999(01)01249-3
15. H Ohtani K Hayashi Y Hirata S Dojo K Nakashima E Nishio H Kurushima M Saeki G Kajiyama 1990 Effects of dietary cholesterol and fatty acids on plasma cholesterol level and hepatic lipoprotein metabolism J Lipid Res 31 1413 1422 1:CAS:528:DyaK3cXlsFWhtrw%3D 2280182
16. G Liu L Fan R Redinger 1991 The association of hepatic apoprotein and lipid metabolism in hamsters and rats Comp Biochem Physiol 99A 223 228 1:CAS:528:DyaK3MXit1Knt7c%3D 10.1016/0300-9629(91)90263-C
17. C Taghibiglou D Rudy SC Van Iderstine A Aiton D Cavallo R Cheung K Adeli 2000 Intracellular mechanism regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes J Lipid Res 41 499 513 1:CAS:528:DC%2BD3cXjt1Chsbk%3D 10744770
18. D Quig C Arbeeney D Zilversmit 1991 Effects of hyperlipidemias in hamsters on lipid transfer protein activity and unidirectional cholesteryl ester transfer in plasma Biochim Biophys Acta 1083 257 264 1:CAS:528: DyaK3MXksVOhtb0%3D 2049390
19. RAK Srivastava 1995 Increased apolipoprotein B100 mRNA by estrogen in inbred strains of mice occurs by decreased mRNA for RNA editing protein mRNA Biochem Biophys Res Commun 212 381 387 1:CAS:528:DyaK2MXntFamt74%3D 10.1006/bbrc.1995.1981 7626051
20. DK Spady JM Dietschy 1988 Interaction of dietary cholesterol and triglycerides in the regulation of hepatic very low density lipoprotein transport in the hamster J Clin Investig 81 300 309 1:CAS:528:DyaL1cXit1Sktb4%3D 10.1172/JCI113321 2448340
21. C Taghibiglou F Rashid-Kolvear SC Van Iderstine H Le-Tien IG Fantus GF Lewis K Adeli 2002 Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance J Biol Chem 277 793 803 1:CAS:528:DC%2BD38XjslGksQ%3D%3D 10.1074/jbc.M106737200 11598116
22. Z Sheng H Otani MS Brown JL Goldstein 1995 Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver Proc Natl Acad Sci USA 92 935 938 1:CAS:528:DyaK2MXjslehtbY%3D 10.1073/pnas.92.4.935 7862668
23. L Berthou N Duverger F Emmanuel S Langouet J Auwerx A Guillouzo JC Fruchart E Rubin P Denefle B Staels D Branellec 1996 Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice J Clin Investig 97 2408 2416 1:CAS:528:DyaK28XjsFKjsrg%3D 10.1172/JCI118687 8647932
24. R Mukherjee KT Locke B Miao D Meyers H Monshizadegan R Zhang D Search D Grimm M Flynn M Kevin KM O'Malley L Zhang J Li Y Shi LJ Kennedy M Blanar PT Cheng J Tino RAK Srivastava 2008 Novel PPARα agonists lower LDL and triglycerides, raise HDL and synergistically increase cholesterol excretion with an LXR agonist J Pharmacol Exp Ther 327 716 726 1:CAS:528:DC%2BD1cXhsVCjtLvM 10.1124/jpet.108.143271 18799592
25. G Chinetti S Lestavel V Bocher AT Remaley B Neve IP Torra E Teissier A Minnich M Jaye N Duverger HB Brewer JC Fruchart V Clavey B Staels 2001 PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat Med 7 1 53 58 1:CAS:528:DC%2BD3MXmvFShtg%3D%3D 10.1038/83348 11135616
26. RAK Srivastava 2002 Estrogen-induced regulation of the ABCA1 in mice: a possible mechanism of atheroprotection by estrogen Mol Cell Biochem 240 67 73 1:CAS:528:DC%2BD38XnvVegsbc%3D 10.1023/A:1020604610873 12487373
27. RAK Srivastava N Srivastava 2000 High-density lipoprotein, apolipoprotein A-I, and coronary artery disease. Review Mol Cell Biochem 209 131 144 1:CAS:528:DC%2BD3cXlt1Gmsb8%3D 10.1023/A:1007111830472 10942211
28. M John JM Galla EM Tuzcu K Wolski S Kalidindi SE Nissen SJ Nicholls 2007 Atherogenic dyslipidemia predicts accelerated progression of atherosclerosis in patients with coronary artery disease Circulation 116 II-285 II-286 (Abstract)
29. V Declercq B Yeganeh GR Moshtaghi-Kashanian H Khademi B Bahadori MH Moghadasian 2005 Paradoxical effects of fenofibrate and nicotinic acid in apoE-deficient mice J Cardiovasc Pharmacol 46 18 24 1:CAS:528: DC%2BD2MXltlSrurs%3D 10.1097/01.fjc.0000162764.12309.25 15965350
30. B Yeganeh GR Moshtaghi-Kashanian V Declercq MH Moghadasian 2005 Combination of dietary phytosterols plus niacin or fenofibrate: effects on lipid profile and atherosclerosis in apoE-KO mice J Nutr Biochem 16 222 228 1:CAS:528:DC%2BD2MXivFSjt74%3D 10.1016/j.jnutbio.2004.12.003 15808326
31. RAK Srivastava 2009 Fenofibrate ameliorates diabetic and dyslipidemic profiles in KKAy mice partly via down-regulation of 11β-HSD1, PEPCK and DGAT2. Comparison of PPARα, PPARγ, and liver x receptor agonists Eur J Pharmacol 607 258 263 1:CAS:528:DC%2BD1MXjsFWlsbY%3D 10.1016/j.ejphar.2009. 02.024 19245804